Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1981-12-21
pubmed:abstractText
1 A number of aromatic-N-propargyl (acetylenic) compounds and indoleamines were tested for their inhibitory action on monoamine oxidase (MAO) type A and type B using the substrates 5-hydroxytryptamine (5-HT), beta-phenylethylamine (PEA) and dopamine. 2 Structure activity studies with aromatic-N-propragyl (acetylenic) derivatives have shown that MAO inhibitory potency is least dependent on the aromatic portion of the compounds. N-methylated propargyl derivatives are the most active and replacement of the methyl group with a higher alkyl or aromatic group results in significant reduction of activity. The triple bond in the N-propargyl portion is absolutely essential for activity and must be beta-to the nitrogen. It is the acetylenic group that gives these compounds their irreversible MAO inhibitory property. 3 The present study has indicated that since the acetylenic compounds resemble the enzyme substrates the distance between the aromatic ring and the N-propargyl terminal is crucial in designating the type A or type B MAO inhibitory property. For MAO type A inhibition, a distance equivalent to at least three carbon units is required, while for the inhibition of the B type enzyme this distance can be 1 or 2 carbon units. 4 The compounds AGN-1133 and AGN-1135 show most promise in Parkinson's disease or as anti-depressants because of their irreversible selective type B MAO inhibition in vitro and in vivo. 5 A number of indoleamine derivatives were found to be reversible selective type A inhibitors.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-1172524, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-1203627, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-13979700, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-14184932, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-14934658, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-4748552, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-481419, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-4850215, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-5054207, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-5066229, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-5659776, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-5960901, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-619909, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-65560, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-6768943, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-6793119, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-708454, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-7262, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-728327, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-745014, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-745015, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-745020, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-834248, http://linkedlifedata.com/resource/pubmed/commentcorrection/7284698-96466
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
73
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
55-64
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1981
pubmed:articleTitle
Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't